Ameriprise’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-66,061
| Closed | -$2.44M | – | 3902 |
|
2023
Q3 | $2.44M | Buy |
66,061
+20,116
| +44% | +$744K | ﹤0.01% | 2729 |
|
2023
Q2 | $1.85M | Sell |
45,945
-13,250
| -22% | -$533K | ﹤0.01% | 2917 |
|
2023
Q1 | $4.29M | Buy |
59,195
+5,858
| +11% | +$425K | ﹤0.01% | 2419 |
|
2022
Q4 | $4.38M | Buy |
53,337
+18,434
| +53% | +$1.51M | ﹤0.01% | 2379 |
|
2022
Q3 | $3.3M | Sell |
34,903
-8,320
| -19% | -$786K | ﹤0.01% | 2517 |
|
2022
Q2 | $8.42M | Sell |
43,223
-11,035
| -20% | -$2.15M | ﹤0.01% | 1870 |
|
2022
Q1 | $12.6M | Buy |
54,258
+7,207
| +15% | +$1.67M | ﹤0.01% | 1716 |
|
2021
Q4 | $18.5M | Buy |
47,051
+16,972
| +56% | +$6.69M | 0.01% | 1477 |
|
2021
Q3 | $13.5M | Buy |
30,079
+415
| +1% | +$186K | ﹤0.01% | 1599 |
|
2021
Q2 | $11.5M | Buy |
29,664
+9,088
| +44% | +$3.53M | ﹤0.01% | 1824 |
|
2021
Q1 | $7.39M | Buy |
20,576
+7,627
| +59% | +$2.74M | ﹤0.01% | 2121 |
|
2020
Q4 | $6.36M | Sell |
12,949
-2,231
| -15% | -$1.09M | ﹤0.01% | 2096 |
|
2020
Q3 | $4.92M | Sell |
15,180
-720
| -5% | -$233K | ﹤0.01% | 2100 |
|
2020
Q2 | $5.79M | Sell |
15,900
-1,359
| -8% | -$495K | ﹤0.01% | 1957 |
|
2020
Q1 | $3.67M | Buy |
17,259
+4,010
| +30% | +$853K | ﹤0.01% | 2113 |
|
2019
Q4 | $5.45M | Buy |
13,249
+176
| +1% | +$72.4K | ﹤0.01% | 2183 |
|
2019
Q3 | $4.62M | Buy |
13,073
+2,734
| +26% | +$965K | ﹤0.01% | 2252 |
|
2019
Q2 | $5.2M | Buy |
10,339
+137
| +1% | +$68.9K | ﹤0.01% | 2233 |
|
2019
Q1 | $10.1M | Buy |
10,202
+4,974
| +95% | +$4.94M | ﹤0.01% | 1695 |
|
2018
Q4 | $4.54M | Sell |
5,228
-1,898
| -27% | -$1.65M | ﹤0.01% | 2180 |
|
2018
Q3 | $7.37M | Sell |
7,126
-5,111
| -42% | -$5.28M | ﹤0.01% | 2097 |
|
2018
Q2 | $11.2M | Sell |
12,237
-4,737
| -28% | -$4.35M | 0.01% | 1639 |
|
2018
Q1 | $16.5M | Buy |
+16,974
| New | +$16.5M | 0.01% | 1262 |
|